نتایج جستجو برای: cd26

تعداد نتایج: 686  

2013
Jonas Söderholm Jesper Waldenström Galia Askarieh Massimo Pilli Pierre-Yves Bochud Francesco Negro Jean-Michel Pawlotsky Stefan Zeuzem Carlo Ferrari Gunnar Norkrans Rune Wejstål Johan Westin Avidan U. Neumann Bart L. Haagmans Magnus Lindh Gabriele Missale Kristoffer Hellstrand Martin Lagging

BACKGROUND Interferon and ribavirin therapy for chronic hepatitis C virus (HCV) infection yields sustained virological response (SVR) rates of 50-80%. Several factors such as non-1 genotype, beneficial IL28B genetic variants, low baseline IP-10, and the functionality of HCV-specific T cells predict SVR. With the pending introduction of new therapies for HCV entailing very rapid clearance of pla...

Journal: : 2023

b-thalassemia là một bệnh rối loạn di truyền lặn do đột biến gen HBB nằm trên cánh ngắn nhiễm sắc thể số 11 gây suy giảm tổng hợp chuỗi b-globin. Mỗi năm có khoảng 60.000 – 70.000 trẻ em sinh ra bị toàn thế giới trong đó Việt Nam. Trên 350 đã được công bố. Phát hiện người lành mang vai trò quan trọng tư vấn truyền, chẩn đoán trước và tiền làm tổ nhằm tỉ lệ bệnh. Nghiên cứu thực với mục tiêu “xá...

ژورنال: پژوهش در پزشکی 2014
احمدزاده, آرمان, بهزادی, موسی, دربندی, حسن, ستاری, ماندانا, قاسمی, عرفان, ولی زاده, مریم, یگانه, فرشید,

Abstract Background: Lupus is one of the most common autoimmune diseases. IFN-α as an important factor in the pathogenesis of lupus has been introduced. Also, CD26 with its enzymatic activity has many roles in the regulation of immune responses. In the current study, we investigated the level of CD26 and IFN-α in the serum of SLE patients. Materials and methods: In this case-control study, 46 S...

2013
Satish Khurana Lia Margamuljana Chacko Joseph Sarah Schouteden Shannon M. Buckley Catherine M. Verfaillie

Hematopoietic stem cells (HSCs) are responsible for maintaining all blood cells throughout the lifetime of an individual, and are used clinically to treat various malignant and nonmalignant disorders. However, for some HSC grafts, for instance from umbilical cord blood (UCB), limited numbers of HSCs restrict their application to pediatric patients. Expanding HSCs in vitro or improving their hom...

2015
Mark I. James Lynne M. Howells Ankur Karmokar Jennifer A. Higgins Peter Greaves Hong Cai Ashley Dennison Matthew Metcalfe Giuseppe Garcea David M. Lloyd David P. Berry William P. Steward Karen Brown

Tumor initiating cells (TIC) are increasingly being put forward as a potential target for intervention within colorectal cancer. Whilst characterisation and outgrowth of these cells has been extensively undertaken in primary colorectal cancers, few data are available describing characteristics within the metastatic setting. Tissue was obtained from patients undergoing surgical resection for col...

Journal: :Organic & biomolecular chemistry 2015
Petko M Ivanov Emanouil J Atanassov Carlos Jaime

The conformations of some 'giant' cyclodextrins (CDn, n = 40, 70, 85, 100) were examined by molecular dynamic simulations using the Glycam06 force field. CD14 and CD26, the largest cyclodextrins, for which crystallographic data are available, were also studied as reference structures. Principal component analysis was used for the analyses of the simulation trajectories. In cases where band-flip...

Journal: :Blood 2013
Satish Khurana Lia Margamuljana Chacko Joseph Sarah Schouteden Shannon M Buckley Catherine M Verfaillie

Directional migration determines hematopoietic stem/progenitor cell (HSPC) homing, which depends upon the interaction between the chemokine CXCL12 and its receptor CXCR4. CD26 is a widely expressed membrane-bound ectopeptidase that cleaves CXCL12 thereby depleting its chemokine activity. We identified tissue-factor pathway inhibitor (TFPI) as a biological inhibitor of CD26 in murine and human H...

Journal: :Blood 2017
Rebecca Warfvinge Linda Geironson Mikael N E Sommarin Stefan Lang Christine Karlsson Teona Roschupkina Leif Stenke Jesper Stentoft Ulla Olsson-Strömberg Henrik Hjorth-Hansen Satu Mustjoki Shamit Soneji Johan Richter Göran Karlsson

Understanding leukemia heterogeneity is critical for the development of curative treatments as the failure to eliminate therapy-persistent leukemic stem cells (LSCs) may result in disease relapse. Here we have combined high-throughput immunophenotypic screens with large-scale single-cell gene expression analysis to define the heterogeneity within the LSC population in chronic phase chronic myel...

Journal: :The Journal of Experimental Medicine 1997
Tamas Oravecz Marina Pall Gregory Roderiquez Mark D. Gorrell Mary Ditto Nga Y. Nguyen Robert Boykins Edward Unsworth Michael A. Norcross

CD26 is a leukocyte activation marker that possesses dipeptidyl peptidase IV activity but whose natural substrates and immunological functions have not been clearly defined. Several chemo-kines, including RANTES (regulated on activation, normal T cell expressed and secreted), have now been shown to be substrates for recombinant soluble human CD26. The truncated RANTES(3-68) lacked the ability o...

Journal: :International journal of oncology 2007
Jarmila Stremenova Evzen Krepela Vladislav Mares Julie Trim Vladimir Dbaly Josef Marek Zdislava Vanickova Vera Lisa Chris Yea Aleksi Sedo

Alterations in dipeptidyl peptidase-IV (DPP-IV) enzymatic activity are characteristic of malignant transformation. Through its well-characterized functionality in regulating the activity of bioactive peptides by removal of the N-terminal dipeptide, DPP-IV activity may have profound effects upon metastatic potential and cell growth. Although DPP-IV/CD26 (EC 3.4.14.5) is the canonical representat...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید